Antibody dynamics on membranes, such as endocytosis and clustering, are vital in determining antibody functions. Yoshiyuki Manabe, Kazuya Kabayama, Koichi Fukase et al. proposed a new approach to modulate its function. In their Communication (e202304779), the was conjugated with galactose-containing N-glycan, internalization suppressed by interaction galectin-3, leading enhancement of complemen...

BACKGROUND AND OBJECTIVES Campath-1H is used in conditioning regimens and more recently as an anti-leukemic therapy in acute lymphoblastic leukemias (ALL). We therefore investigated CD52 expression and campath-1H-mediated lysis of ALL cells in vitro. DESIGN AND METHODS Complement-mediated cytotoxicity assays were performed on freshly isolated neoplastic cells and cell lines using human serum....

Despite the success of anti-CD20 monoclonal antibody (mAb) in the treatment of lymphoma, there remains considerable uncertainty about their mechanism(s) of action. Here, we show that certain of these reagents (rituximab and 1F5), which redistribute CD20 into membrane rafts, are bound efficiently by C1q, deposit C3b, and result in complement-dependent cytotoxicity (CDC). This activity is importa...

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to astrocytes causes complement-dependent cytotoxicity (CDC) and inflammation resulting in oligodendrocyte and neuronal injury. There is compelling evidence for a central role of complement in NMO pathogenesis. Here, we evaluated th...

Submit Manuscript | http://medcraveonline.com Abbreviations: CDC: Complement Dependent Cytotoxicity; FCXM: Flow-Cytometry Crossmatch; SAB: Single Antigen Bead; ESRD: End Stage Renal Disease; AMR: Antibody Mediated Rejection; DSA: Donor Specific Antibodies; MFI: Mean Fluorescence Intensity; DSA: Donor Specific Antibodies; HLA: Human Leukocyte Antigens; PRA: Panel Reactive Antibody; MCS: Median C...

BACKGROUND AND OBJECTIVES Various methods have been reported for the detection of antibodies in recipient sera, which can be human leukocyte antigens (HLAs) or non-HLA specific, complement- or noncomplement fixing, as well as donor T (HLA-Class-I) and/or B cell (HLA-Class-I and II) specific. These alloantibodies play a pivotal role in antibody-mediated renal transplantation rejection. Depositio...

Submit Manuscript | http://medcraveonline.com Abbreviations: ADCC: Antibody Dependent Cell Mediated Cytotoxicity; CDC: Complement Dependent Cytotoxicity; CTL: Cytotoxic T lymphocyte; DC: Dendritic Cell; GM-CSF: GranulocyteMacrophage Colony Stimulating Factor; HPV: Human Papilloma Virus; HBV: Hepatitis B Virus; IL-2: Interleukin 2; IL-12: Interleukin 12; IFN: Interferon; MHC: Major Histocompatib...

Abbreviations: SCID-X1: X-linked Severe Combined Immunodeficiency; γc: Cytokine Receptor Common Gamma Chain; HSC: Hematopoietic Stem Cells; ab: Antibody; wt: Wild-type; NK cell: Natural Killer Cell; HLA: Human Leukocyte Antigen; SIN: Selfinactivating; HSV-TK: Thymidine kinase of Herpes Simplex Virus; ER: Endoplasmatic Reticulum; MFI: Mean Fluorescence Intensity; CDC: Complement-dependent Cytoto...

Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting lymphocytes by cytolytic effects in vivo. Although the cytolytic effects of alemtuzumab are dependent on the density of CD52 antigen on cells, there is scant information regarding the expression levels of CD52 on different cell types. In this study, CD52 expression was assessed on phenotypically di...

The anti-CD20 chimeric monoclonal antibody rituximab mediates cytotoxicity in malignant B cells via multiple mechanisms, including complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC) and direct induction of apoptosis. To optimize treatment of non-Hodgkin's lymphoma, a fuller understanding of these mechanisms and their relative contributions to clinical effic...